Trial NCT00509366

View at ClinicalTrials.gov 
Org. Study IDs: Pro00004599

Last trial update was posted on 2014-08-28

MeSH Interventions

Cisplatin Docetaxel Gemcitabine Pemetrexed

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non Small Cell Lung Cancer

Stopping Reasons

Study terminated due to reproducibility issues with genomics prediction model.

Limitations And Caveats

The microarray-based prediction model of chemotherapy sensitivity, used to allocate patients into the cisplatin treatment arms, was irreproducible and inaccurate. Quality of life measurements were incomplete and could not be analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID